Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis c therapy among patients coinfected with hepatitis c and HIV

Nimish Patel; Michael Veve; Mona Nasiri; Steven Bliss; Louise Anne McNutt; Victoria Lazariu; Christopher Miller

doi:10.1089/apc.2014.0149

Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis c therapy among patients coinfected with hepatitis c and HIV

Nimish Patel
, Michael Veve
, Mona Nasiri
, Steven Bliss
, Louise Anne McNutt
, Victoria Lazariu
, Christopher Miller

Institute for Health & The Environment

University at Albany

Albany College of Pharmacy
SUNY Albany
SUNY Upstate Medical University

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	513-516
Number of pages	4
Journal	AIDS Patient Care and STDs
Volume	28
Issue number	10
DOIs	https://doi.org/10.1089/apc.2014.0149
State	Published - 2014

Access to Document

10.1089/apc.2014.0149

Cite this

@article{c540e5039fe2469fae6c68a2174c740e,

title = "Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis c therapy among patients coinfected with hepatitis c and HIV",

author = "Nimish Patel and Michael Veve and Mona Nasiri and Steven Bliss and McNutt, \{Louise Anne\} and Victoria Lazariu and Christopher Miller",

year = "2014",

doi = "10.1089/apc.2014.0149",

language = "English",

volume = "28",

pages = "513--516",

journal = "AIDS Patient Care and STDs",

issn = "1087-2914",

publisher = "Mary Ann Liebert Inc.",

number = "10",

}

Patel, N, Veve, M, Nasiri, M, Bliss, S, McNutt, LA, Lazariu, V & Miller, C 2014, 'Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis c therapy among patients coinfected with hepatitis c and HIV', AIDS Patient Care and STDs, vol. 28, no. 10, pp. 513-516. https://doi.org/10.1089/apc.2014.0149

Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis c therapy among patients coinfected with hepatitis c and HIV. / Patel, Nimish; Veve, Michael; Nasiri, Mona et al.
In: AIDS Patient Care and STDs, Vol. 28, No. 10, 2014, p. 513-516.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis c therapy among patients coinfected with hepatitis c and HIV

AU - Patel, Nimish

AU - Veve, Michael

AU - Nasiri, Mona

AU - Bliss, Steven

AU - McNutt, Louise Anne

AU - Lazariu, Victoria

AU - Miller, Christopher

PY - 2014

Y1 - 2014

UR - https://www.scopus.com/pages/publications/84907605347

U2 - 10.1089/apc.2014.0149

DO - 10.1089/apc.2014.0149

M3 - Letter

C2 - 25093994

SN - 1087-2914

VL - 28

SP - 513

EP - 516

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

IS - 10

ER -

Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis c therapy among patients coinfected with hepatitis c and HIV

Access to Document

Other files and links

Fingerprint

Cite this